IDYA

IDEAYA Biosciences, Inc. · Healthcare · Market cap $3.1B

Insiders sold $985K net in the last 90 days ·1 seller, 0 buyers· 1 of 1 sale under Rule 10b5-1 plans· latest Form 4 filed Oct 8, 2026

Insider Buying

$1.6M

reported purchases (SEC code P)

Insider Selling

$1.4M

reported sales (SEC code S)

Unique Insiders

3

in the rolling window

Latest filing

Oct 8, 2026

Hata Yujiro S

IDEAYA Biosciences, Inc. (IDYA) has 5 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Oct 8, 2026.

Inside the rolling window, 3 insiders at IDEAYA Biosciences, Inc. reported 1 open-market purchase totaling $1.6M and 2 open-market sales totaling $1.4M. Insiders have net sold $1.4M over the trailing 6 months. The most recent open-market filing is a sale of 26,338 shares by President and CEO Hata Yujiro S, dated Oct 6, 2026, worth $985K.

  • Industry:Biotechnology
  • CEO:Yujiro S. Hata
  • Employees:145
  • HQ:South San Francisco, CA, US
  • IPO:2019-05-23
Source
Hata Yujiro SFirst filing
Sale$985KOct 8SEC ↗
Sale$382KJul 9SEC ↗
Purchase$1.6MMar 2SEC ↗
Showing 1–3 of 3
1 / 1

Frequently asked questions

How many SEC Form 4 insider filings does IDYA have?

IDEAYA Biosciences, Inc. (IDYA) has 5 SEC Form 4 filings (10 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Oct 8, 2026.

When was the most recent SEC Form 4 filing for IDYA?

The most recent Form 4 filing for IDYA on Tracefour is dated Oct 8, 2026.

What is the net insider flow at IDYA over the last 6 months?

Over the trailing 180 days, insiders at IDYA have net sold $1.4M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at IDYA in the current window?

Inside the rolling window, insiders at IDYA bought $1.6M and sold $1.4M based on SEC Form 4 filings.

Can I get alerts for IDYA insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at IDEAYA Biosciences, Inc. (IDYA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

IDEAYA Biosciences, Inc. is in the Healthcare sector.